Drugs / Valomaciclovir
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00831103 | Nov 2007 → Jun 2009 | herpes zoster | Epiphany Biosciences | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00575185 Comparator | Nov 2007 → Jul 2009 | infectious mononucleosis | University of Minnesota | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Valomaciclovir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00575185 ↗ |
| Known as | EPB-348 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00831103 ↗ |
| Modality | Small molecule | — CHEMBL2107301 ↗ |
| Route | Oral | “Valomaciclovir 2 grams orally twice daily for 21 days” NCT00575185 ↗ |